Literature DB >> 6371069

Nail changes secondary to systemic drugs or ingestants.

C R Daniel, R K Scher.   

Abstract

Systemic drugs often affect the nails. These changes range from mild pigmentation abnormalities to nail shedding and matrix scarring. The purpose of this article is to provide a handy reference for the physician who is confronted with nail disorders that may be due to systemic drugs or ingestants.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6371069     DOI: 10.1016/s0190-9622(84)70032-6

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

Review 1.  Drug-induced nail disorders: incidence, management and prognosis.

Authors:  B M Piraccini; A Tosti
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.606

2.  Docetaxel-induced nail changes--a neurogenic mechanism: a case report.

Authors:  Gunnar Wasner; Felix Hilpert; Jörn Schattschneider; Andreas Binder; Jacobus Pfisterer; Ralf Baron
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

3.  Onychodystrophy and its management.

Authors:  Tilmann Oppel; Hans Christian Korting
Journal:  Ger Med Sci       Date:  2003-07-01

4.  An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010.

Authors:  Sung-Hsi Wei; Yuan-Pin Huang; Ming-Chih Liu; Tsung-Pei Tsou; Hui-Chen Lin; Tsuey-Li Lin; Chen-Yen Tsai; Yen-Nan Chao; Luan-Yin Chang; Chun-Ming Hsu
Journal:  BMC Infect Dis       Date:  2011-12-14       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.